A randomized controlled trial of the efficacy and safety of lisdexamfetamine dimesylate as augmentation therapy in adults with residual symptoms of major depressive disorder after treatment with escitalopram / Madhukar H. Trivedi en The Journal of Clinical Psychiatry, Año 2013 - Vol.74 - No.8 (Agosto)

Público ISBD [artículo]  inThe Journal of Clinical Psychiatry > Año 2013 - Vol.74 - No.8 (Agosto) . - pp. 802-809 Título : A randomized controlled trial of the efficacy and safety of lisdexamfetamine dimesylate as augmentation therapy in adults with residual symptoms of major depressive disorder after treatment with escitalopram Tipo de documento: texto impreso Autores: Madhukar H. Trivedi, Autor ; Andrew J. Cutler, Autor ; Cynthia Richards, Autor Fecha de publicación: 2022 Artículo en la página: pp. 802-809 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antidepresivos, Estimulantes del sistema nervioso central, Citalopram, Trastorno depresivo mayor, Dextroanfetamina, Terapia farmacológica, Psicometría. Resumen: Evaluate the efficacy and safety of lisdexamfetamine dimesylate augmentation for major depressive disorder (MDD) in escitalopram nonremitters. Link: ./index.php?lvl=notice_display&id=27876 [artículo] A randomized controlled trial of the efficacy and safety of lisdexamfetamine dimesylate as augmentation therapy in adults with residual symptoms of major depressive disorder after treatment with escitalopram [texto impreso] / Madhukar H. Trivedi, Autor ; Andrew J. Cutler, Autor ; Cynthia Richards, Autor . - 2022 . - pp. 802-809. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The Journal of Clinical Psychiatry > Año 2013 - Vol.74 - No.8 (Agosto) . - pp. 802-809 Palabras clave: Antidepresivos, Estimulantes del sistema nervioso central, Citalopram, Trastorno depresivo mayor, Dextroanfetamina, Terapia farmacológica, Psicometría. Resumen: Evaluate the efficacy and safety of lisdexamfetamine dimesylate augmentation for major depressive disorder (MDD) in escitalopram nonremitters. Link: ./index.php?lvl=notice_display&id=27876

A randomized controlled trial of the efficacy and safety of lisdexamfetamine dimesylate as augmentation therapy in adults with residual symptoms of major depressive disorder after treatment with escitalopram / Madhukar H. Trivedi en The Journal of Clinical Psychiatry, Año 2013 - Vol.74 - No.8 (Agosto)

Público ISBD [artículo]  inThe Journal of Clinical Psychiatry > Año 2013 - Vol.74 - No.8 (Agosto) . - pp. 802-809 Título : A randomized controlled trial of the efficacy and safety of lisdexamfetamine dimesylate as augmentation therapy in adults with residual symptoms of major depressive disorder after treatment with escitalopram Tipo de documento: texto impreso Autores: Madhukar H. Trivedi, Autor ; Andrew J. Cutler, Autor ; Cynthia Richards, Autor Fecha de publicación: 2022 Artículo en la página: pp. 802-809 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antidepresivos, Estimulantes del sistema nervioso central, Citalopram, Trastorno depresivo mayor, Dextroanfetamina, Terapia farmacológica, Psicometría. Resumen: Evaluate the efficacy and safety of lisdexamfetamine dimesylate augmentation for major depressive disorder (MDD) in escitalopram nonremitters. Link: ./index.php?lvl=notice_display&id=27877 [artículo] A randomized controlled trial of the efficacy and safety of lisdexamfetamine dimesylate as augmentation therapy in adults with residual symptoms of major depressive disorder after treatment with escitalopram [texto impreso] / Madhukar H. Trivedi, Autor ; Andrew J. Cutler, Autor ; Cynthia Richards, Autor . - 2022 . - pp. 802-809. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The Journal of Clinical Psychiatry > Año 2013 - Vol.74 - No.8 (Agosto) . - pp. 802-809 Palabras clave: Antidepresivos, Estimulantes del sistema nervioso central, Citalopram, Trastorno depresivo mayor, Dextroanfetamina, Terapia farmacológica, Psicometría. Resumen: Evaluate the efficacy and safety of lisdexamfetamine dimesylate augmentation for major depressive disorder (MDD) in escitalopram nonremitters. Link: ./index.php?lvl=notice_display&id=27877

---

1 (1 - 2 / 2)